Cardinal Capital Management Regeneron Pharmaceuticals, Inc. Transaction History

Cardinal Capital Management

$610 Million
Q1 2024

A detailed history of Cardinal Capital Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cardinal Capital Management holds 7,774 shares of REGN stock, worth $8.04 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

7,774

Previous 7,490 3.79%

Holding current value

$8.04 Million

Previous $6.58 Million 13.74%

% of portfolio

1.23%

Previous 1.25%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$902.69 - $993.35 $256,363 - $282,111	284 Added 3.79%	7,774 $7.48 Million
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $12,402 - $14,107	-16 Reduced 0.21%	7,490 $6.58 Million
Q3 2023 Oct 16, 2023	BUY	$692.45 - $844.37 $60,935 - $74,304	88 Added 1.19%	7,506 $6.18 Million
Q2 2023 Jul 12, 2023	BUY	$700.03 - $830.35 $39,901 - $47,329	57 Added 0.77%	7,418 $5.33 Million
Q1 2023 Apr 18, 2023	SELL	$680.49 - $826.97 $37,426 - $45,483	-55 Reduced 0.74%	7,361 $6.05 Million

Q4 2022 Jan 20, 2023	SELL	$705.89 - $766.39 $32,470 - $35,253	-46 Reduced 0.62%	7,416 $0
Q3 2022 Oct 21, 2022	BUY	$573.97 - $724.32 $39,029 - $49,253	68 Added 0.92%	7,462 $5.14 Million
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $16,450 - $22,165	30 Added 0.41%	7,394 $4.37 Million
Q1 2022 Apr 21, 2022	BUY	$595.12 - $698.43 $77,365 - $90,795	130 Added 1.8%	7,364 $5.14 Million
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $11,956 - $14,761	-22 Reduced 0.3%	7,234 $4.57 Million
Q3 2021 Oct 21, 2021	SELL	$574.03 - $680.96 $47,644 - $56,519	-83 Reduced 1.13%	7,256 $4.39 Million
Q2 2021 Jul 14, 2021	SELL	$472.8 - $558.54 $11,820 - $13,963	-25 Reduced 0.34%	7,339 $4.1 Million
Q1 2021 Apr 19, 2021	BUY	$446.73 - $548.2 $42,886 - $52,627	96 Added 1.32%	7,364 $3.48 Million
Q4 2020 Feb 01, 2021	BUY	$478.3 - $607.98 $31,567 - $40,126	66 Added 0.92%	7,268 $3.51 Million
Q3 2020 Oct 16, 2020	SELL	$544.75 - $658.21 $3,813 - $4,607	-7 Reduced 0.1%	7,202 $4.03 Million
Q2 2020 Jul 16, 2020	SELL	$493.32 - $643.92 $14,306 - $18,673	-29 Reduced 0.4%	7,209 $4.5 Million
Q1 2020 Apr 20, 2020	BUY	$336.18 - $494.43 $100,517 - $147,834	299 Added 4.31%	7,238 $3.53 Million
Q4 2019 Jan 21, 2020	BUY	$274.13 - $376.51 $1.9 Million - $2.61 Million	6,939 New	6,939 $2.61 Million

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Account

Cardinal Capital Management Regeneron Pharmaceuticals, Inc. Transaction History